Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-05-13

FDA Approved: ZIDOVUDINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Zidovudine from Aurobindo Pharma Limited, authorizing changes under the approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zidovudine (Zidovudine)

Snippet

SUPPL AP for ZIDOVUDINE (ZIDOVUDINE)